Sacheon, South Korea

Hyun-Ju Cho

This inventor holds 1 USPTO granted patent. Top assignee: Korea Institute of Science and Technology. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hyun-Ju Cho. Retrieved from https://idiyas.com/inventor/hyun-ju-cho-u60m4ot8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hyun-Ju Cho: Innovator in Protein Interaction Analysis

Introduction

Hyun-Ju Cho is a notable inventor based in Sacheon, South Korea. He has made significant contributions to the field of protein interaction analysis, particularly in understanding the mechanisms involving HIF-1alpha and its associated proteins.

Latest Patents

Hyun-Ju Cho holds a patent titled "Method for quantitative analysis of interactions between HIF-1alpha C-terminal peptides and CBP or p300 proteins and method of screening inhibitors using the same." This innovative method allows for the quantitative analysis of interactions between fluorescein-labeled HIF-1alpha C-terminal peptides and cAMP-responsive element binding protein (CBP) or p300 proteins. Additionally, it provides a method for screening inhibitors that target the formation of HIF-1alpha-p300 or HIF-1alpha-CBP protein complexes.

Career Highlights

Hyun-Ju Cho is affiliated with the Korea Institute of Science and Technology, where he continues to advance research in his field. His work has garnered attention for its potential applications in therapeutic development.

Collaborations

Some of his notable coworkers include Eun-Gyeong Yang and Dae-Ro Ahn, who contribute to the collaborative research efforts at the Korea Institute of Science and Technology.

Conclusion

Hyun-Ju Cho's innovative work in protein interaction analysis exemplifies the importance of research in understanding complex biological systems. His contributions are paving the way for future advancements in therapeutic strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…